HYPOTONY AND ANTERIOR CHAMBER MIGRATION OF IMPLANT AS COMPLICATIONS OF INTRAVITREAL DEXAMETHASONE IMPLANTATION IN A UVEITIS PATIENT -- A CASE REPORT

葡萄膜炎患者玻璃體內類固醇植入物之低眼壓及前房位移之併發症

林俊賢(Chun-Hsien Lin) ； 王璟煜(Ching-Yu Wang) ； 黃德光(De-Kuang Hwang)

《中華民國眼科醫學會雜誌》 55卷 (2016/12) Pp. 88-92

https://doi.org/10.30048/ACTASOS.201612_55.0014

摘要

Purpose: To report a case that experienced complications after intravitreal dexamethasone implantation. Method: Case report Results: A 42-year-old female with persistent panuveitis was treated by intravitreal injection of dexamethasone implant. Unfortunately, hypotony and anterior chamber migration of the implant were noted on the first day postoperatively. Emergent surgery was performed. After a few weeks of close follow-up, a stable condition was achieved without permanent intraocular damage. Conclusion: Intravitreal injection of dexamethasone implant is usually safe and effective. However, surgically related complications may occur in patients with some complicated ocular conditions. Clinical ophthalmologists should be especially mindful of the possibility of complications following intravitreal injection of dexamethasone implant for the treatment of persistent panuveitis in such patients.

關鍵字

Anterior chamber migration ； Dexamethasone implant ； Hypotony ； Uveitis

並列摘要

目的：報告一名玻璃體內類固醇植入物後產生併發症之病例。方法：病例報告。結果：一位42歲女性，因持續全葡萄膜炎接受玻璃體內類固醇植入物注射。注射後第一天產生低眼壓及類固醇植入物前房位移之併發症，因此接受緊急手術。在幾週的密切觀察之後，情況穩定並且沒有產生永久性的眼內傷害。結論：玻璃體內類固醇植入物注射通常是安全及有效的治療方式。然而，手術相關的併發症，在眼睛情況較複雜的患者仍可能發生。臨床醫師在面對這類持續性全葡萄膜炎患者，使用玻璃體內類固醇植入物注射治療時，應特別注意有產生併發症的可能性。